{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T10:23:28Z","timestamp":1772706208348,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"National Nature Science Foundation Project of China","award":["81270915"],"award-info":[{"award-number":["81270915"]}]},{"name":"Nature Science Foundation Project of Guangdong Province","award":["2015A030313042"],"award-info":[{"award-number":["2015A030313042"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12944-016-0368-3","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T04:56:47Z","timestamp":1479877007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A2 and secretory phospholipase A2 in patients with newly diagnosed type 2 diabetes"],"prefix":"10.1186","volume":"15","author":[{"given":"Xiu-hong","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-tong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jv-ying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-fang","family":"Mai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,23]]},"reference":[{"key":"368_CR1","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2013.168118","volume":"310","author":"Y Xu","year":"2013","unstructured":"Xu Y, Wang L, He J, Bi Y, Li M, Wang T, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310:948\u201359.","journal-title":"JAMA"},{"issue":"Suppl 1","key":"368_CR2","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc13-S011","volume":"36","author":"American Diabetes Association","year":"2013","unstructured":"American Diabetes Association. Standards of medical care in diabetes\u20142013. Diabetes Care. 2013;36 Suppl 1:S11\u201366.","journal-title":"Diabetes Care"},{"key":"368_CR3","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1161\/01.CIR.0000013954.65303.C5","volume":"105","author":"RH Eckel","year":"2002","unstructured":"Eckel RH, Wassef M, Chait A, Sobel B, Barrett E, King G, et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes. Circulation. 2002;105:e138\u201343.","journal-title":"Circulation"},{"key":"368_CR4","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.2337\/diabetes.51.5.1596","volume":"51","author":"DJ Freeman","year":"2002","unstructured":"Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, et al. C reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevntion Study. Diabetes. 2002;51:1596\u2013600.","journal-title":"Diabetes"},{"key":"368_CR5","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2337\/diabetes.51.4.1131","volume":"51","author":"A Festa","year":"2002","unstructured":"Festa A, D\u2019Agostino Jr R, Tracy RP, Haffner SM. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes mellitus: the Insulin Resistance Atherosclerosis Study (IRSA). Diabetes. 2002;51:1131\u20137.","journal-title":"Diabetes"},{"key":"368_CR6","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.2337\/db11-0275","volume":"60","author":"SK Yekollu","year":"2011","unstructured":"Yekollu SK, Thomas R, O\u2019Sulivan B. Targeting curcusomes to inflammatory dendritic cells inhibits NF-\u03baB and improves insulin resistance in obese mice. Diabetes. 2011;60:2928\u201338.","journal-title":"Diabetes"},{"key":"368_CR7","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1161\/CIRCULATIONAHA.110.936393","volume":"122","author":"Z Mallat","year":"2010","unstructured":"Mallat Z, Lambeau G, Tedgui A. Lipoprotein-associated and secreted phospholipases A in cardiovascular disease: roles as biological effectors and biomarkers. Circulation. 2010;122:2183\u2013200.","journal-title":"Circulation"},{"issue":"2","key":"368_CR8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejvs.2011.10.009","volume":"43","author":"G Sarlon-Bartoli","year":"2012","unstructured":"Sarlon-Bartoli G, Boudes A, Buffat C, Bartoli MA, Piercecchi-Marti MD, Sarlon E, et al. Circulating lipoprotein-associated phospholipase A2 in high-grade carotid stenosis: a new biomarker for predicting unstable plaque. Eur J Vasc Endovasc Surg. 2012;43(2):154\u20139.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"368_CR9","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1742-4658.2004.04489.x","volume":"272","author":"S Masuda","year":"2005","unstructured":"Masuda S, Murakami M, Komiyama K, Ishihara M, Ishikawa Y, Ishii T, Kudo I. Various secretory phospholipase A2 enzymes are expressed in rheumatoid arthritis and augment prostaglandin production in cultured synovial cells. FEBS J. 2005;272:655\u201372.","journal-title":"FEBS J"},{"issue":"1","key":"368_CR10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1620\/tjem.207.65","volume":"207","author":"H Oshimoto","year":"2005","unstructured":"Oshimoto H, Okamura S, Iida T, Ishikawa T, Hosaka K, Mori M. Diagnostic value of the serum platelet-activating factor acetylhydrolase activity in inflammatory bowel disease. Tohoku J Exp Med. 2005;207(1):65\u201371.","journal-title":"Tohoku J Exp Med"},{"key":"368_CR11","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1210\/jc.2011-3026","volume":"97","author":"TL Nelson","year":"2012","unstructured":"Nelson TL, Biggs ML, Kizer JR, Cushman M, Hokanson JE, Furberg CD, Mukamal KJ. Lipoprotein-associated phospholipase A2 (Lp-PLA2) and future risk of type 2 diabetes: results from the Cardiovascular Health Study. J Clin Endocrin Metab. 2012;97:1695\u2013701.","journal-title":"J Clin Endocrin Metab"},{"key":"368_CR12","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(10)60319-4","volume":"375","author":"A Thompson","year":"2010","unstructured":"Thompson A, Gao P, Orfei L, Watson S, Di Angelantonio E, Kaptoge S, et al. Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet. 2010;375:1536\u201344.","journal-title":"Lancet"},{"key":"368_CR13","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0140-6736(08)60762-X","volume":"371","author":"J Weng","year":"2008","unstructured":"Weng J, Li Y, Xu W, Shi L, Zhang Q, Zhu D, et al. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet. 2008;371:1753\u201360.","journal-title":"Lancet"},{"key":"368_CR14","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577\u201389.","journal-title":"N Engl J Med"},{"key":"368_CR15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.diabres.2009.04.004","volume":"86","author":"ZH Wang","year":"2009","unstructured":"Wang ZH, Zhang SH, Gong LL, Ren W, Li R, Zheng RZ, et al. The impact of family history of type 2 diabetes on pancreatic \u03b2 cell function. Diabetes Res Clin Pract. 2009;86:61\u20136.","journal-title":"Diabetes Res Clin Pract"},{"key":"368_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12872-015-0001-9","volume":"15","author":"A Cai","year":"2015","unstructured":"Cai A, Li G, Chen J, Li X, Li L, Zhou Y. Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population. BMC Cardiovasc Disord. 2015;15:14. doi: 10.1186\/s12872-015-0001-9 .","journal-title":"BMC Cardiovasc Disord"},{"key":"368_CR17","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1365-2362.2011.02471.x","volume":"41","author":"A Constantinides","year":"2011","unstructured":"Constantinides A, van Pelt LJ, van Leeuwen JJ, de Vries R, Tio RA, van der Horst IC, et al. Carotid intima media thickness is associated with plasma lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in patients with type 2 diabetes. Eur J Clin Invest. 2011;41:820\u20137.","journal-title":"Eur J Clin Invest"},{"key":"368_CR18","doi-asserted-by":"crossref","first-page":"278063","DOI":"10.1155\/2014\/278063","volume":"2014","author":"J Fortunato","year":"2014","unstructured":"Fortunato J, Blaha V, Bis J, St\u2019asek J, Andrys C, Vojacek J, et al. Lipoprotein-associated phospholipase A2 mass level is increased in elderly subjects with type 2 diabetes mellitus. J Diabetes Res. 2014;2014:278063.","journal-title":"J Diabetes Res"},{"key":"368_CR19","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1194\/jlr.R024190","volume":"53","author":"RS Rosenson","year":"2012","unstructured":"Rosenson RS, Stafforini DM. Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2. J Lipid Res. 2012;53:1767\u201382.","journal-title":"J Lipid Res"},{"key":"368_CR20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1475-2840-12-112","volume":"12","author":"JL Sanchez-Quesada","year":"2013","unstructured":"Sanchez-Quesada JL, Vinagre I, De Juan-Franco E, Sanchez-Hernandez J, Bonet-Marques R, Blanco-Vaca F, et al. Impact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetes. Cardiovasc Diabetol. 2013;12:112.","journal-title":"Cardiovasc Diabetol"},{"key":"368_CR21","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/nm.1870","volume":"14","author":"RL Wilensky","year":"2008","unstructured":"Wilensky RL, Shi Y, Mohler ER, Hamamdzic D, Burgert ME, Li J, et al. Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat Med. 2008;14:1059\u201366.","journal-title":"Nat Med"},{"key":"368_CR22","doi-asserted-by":"crossref","first-page":"e23425","DOI":"10.1371\/journal.pone.0023425","volume":"6","author":"WY Wang","year":"2011","unstructured":"Wang WY, Zhang J, Wu WY, Li J, Ma YL, Chen WH, et al. Inhibition of lipoprotein-associated phospholipase A2 ameliorates inflammation and decreases atherosclerotic plaque formation in ApoE-deficient mice. PLoS One. 2011;6:e23425.","journal-title":"PLoS One"},{"key":"368_CR23","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jama.2014.11061","volume":"312","author":"ML O\u2019Donoghue","year":"2014","unstructured":"O\u2019Donoghue ML, Braunwald E, White HD, Lukas MA, Tarka E, Steg PG, et al. Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial. JAMA. 2014;312:1006\u201315.","journal-title":"JAMA"},{"key":"368_CR24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10557-011-6344-2","volume":"25","author":"RS Rosenson","year":"2011","unstructured":"Rosenson RS, Fraser H, Goulder MA, Hislop C. Anti-Inflammatory effects of varespladib methyl in diabetic patients with acute coronary syndrome. Cardiovasc Drugs Ther. 2011;25:539\u201344.","journal-title":"Cardiovasc Drugs Ther"},{"key":"368_CR25","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5414\/CNP63356","volume":"63","author":"GJ Vlachojannis","year":"2005","unstructured":"Vlachojannis GJ, Scholz-Pedretti K, Fierlbeck W. Enhanced expression of group IIA secreted phospholipase A2 by elevated glucose levels in cytokine-stimulated rat mesangial cells and in kidneys of diabetic rats. Clin Bephrol. 2005;63:356\u201367.","journal-title":"Clin Bephrol"},{"key":"368_CR26","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1161\/01.ATV.0000217284.86123.2c","volume":"26","author":"T Okada","year":"2006","unstructured":"Okada T, Miyashita M, Kuromori Y, Iwata F, Harada K, Hattori H. Platelet-activating factor acetylhydrolase concentration in children with abdominal obesity. Arterioscler Thromb Vasc Biol. 2006;26:e40\u20131.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"368_CR27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/thx.2006.074112","volume":"63","author":"NL Misso","year":"2008","unstructured":"Misso NL, Petrovic N, Grove C, Celenza A, Brooks-Wildhaber J, Thompson PJ. Plasma phospholipase A2 activity in patients with asthma: association with body mass index and cholesterol concentration. Thorax. 2008;63:21\u20136.","journal-title":"Thorax"},{"key":"368_CR28","first-page":"30","volume":"45","author":"DH Wan","year":"2010","unstructured":"Wan DH, Fan P, Bai H, Song Q, Liu HW. Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance. Zhonghua Fu Chan Ke Za Zhi. 2010;45:30\u20134.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"368_CR29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0929-7855(97)00023-0","volume":"17","author":"GB Kudolo","year":"1997","unstructured":"Kudolo GB, Bressler P, DeFrozo RA. Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment. J Lipid Mediat Cell Signal. 1997;17:97\u2013113.","journal-title":"J Lipid Mediat Cell Signal"},{"key":"368_CR30","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s11695-007-9113-3","volume":"17","author":"D Konukoglu","year":"2007","unstructured":"Konukoglu D, Uzun H, Firtina S, Cigdem Arica P, Kocael A, Taskin M. Plasma adhesion and inflammation markers: asymmetrical dimethyl-L-arginine and secretory phospholipase A2 concentrations before and after laparoscopic gastric banding in morbidly obese patients. Obes Surg. 2007;17:672\u20138.","journal-title":"Obes Surg"},{"key":"368_CR31","doi-asserted-by":"crossref","first-page":"606","DOI":"10.2337\/db07-1356","volume":"57","author":"JE Friedman","year":"2008","unstructured":"Friedman JE, Kirwan JP, Jing M, Presley L, Catalano PM. Increased skeletal muscle tumor necrosis factor-\u03b1 and impaired insulin signaling persist in obese women with gestational diabetes mellitus 1\u00a0year postpartum. Diabetes. 2008;57:606\u201313.","journal-title":"Diabetes"},{"key":"368_CR32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","volume":"11","author":"DS Cai","year":"2005","unstructured":"Cai DS, Yuan MS, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE. Local and systemic insulin resistance resulting from hepatic activation of IKK-\u03b2 and NF-\u03baB. Nat Med. 2005;11:183\u201390.","journal-title":"Nat Med"},{"key":"368_CR33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jdiacomp.2006.07.004","volume":"20","author":"H Noto","year":"2006","unstructured":"Noto H, Chitkara P, Raskin P. The role of lipoprotein-associated phospholipase A(2) in the metabolic syndrome and diabetes. J Diabetes Complications. 2006;20:343\u20138.","journal-title":"J Diabetes Complications"},{"key":"368_CR34","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.atherosclerosis.2007.02.012","volume":"196","author":"M Iwase","year":"2008","unstructured":"Iwase M, Sonoki K, Sasaki N, Ohdo S, Higuchi S, Hattori H, Iida M. Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment. Atherosclerosis. 2008;196:931\u20136.","journal-title":"Atherosclerosis"},{"key":"368_CR35","first-page":"139","volume":"49","author":"Y Huang","year":"2011","unstructured":"Huang Y, Fu JF, Shi HB, Liu LR. Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2\/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes. Zhonghua Er Ke Za Zhi. 2011;49:139\u201345.","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"368_CR36","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0005-2760(97)00189-6","volume":"1390","author":"S Ramanadham","year":"1998","unstructured":"Ramanadham S, Ma Z, Arita H, Zhang S, Turk J. Type IB secretory phospholipase A2 is contained in insulin secretory granules of pancreatic islet beta-cells and is co-secreted with insulin from glucose-stimulated islets. Biochim Biophys Acta. 1998;1390:301\u201312.","journal-title":"Biochim Biophys Acta"},{"key":"368_CR37","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ejim.2014.05.010","volume":"25","author":"O Mayer Jr","year":"2014","unstructured":"Mayer Jr O, Seidlerova J, Filipovsky J, Timoracka K, Bruthans J, Vanek J. Unexpected inverse relationship between impaired glucose metabolism and lipoprotein-associated phospholipase A2 activity in patients with stable vascular disease. Eur J Intern Med. 2014;25:556\u201360.","journal-title":"Eur J Intern Med"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-016-0368-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T04:15:46Z","timestamp":1498364146000},"score":1,"resource":{"primary":{"URL":"http:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-016-0368-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,23]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["368"],"URL":"https:\/\/doi.org\/10.1186\/s12944-016-0368-3","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,23]]},"article-number":"203"}}